These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

425 related articles for article (PubMed ID: 29106063)

  • 1. Cannabinoid-1 receptor deletion in podocytes mitigates both glomerular and tubular dysfunction in a mouse model of diabetic nephropathy.
    Jourdan T; Park JK; Varga ZV; Pálóczi J; Coffey NJ; Rosenberg AZ; Godlewski G; Cinar R; Mackie K; Pacher P; Kunos G
    Diabetes Obes Metab; 2018 Mar; 20(3):698-708. PubMed ID: 29106063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy.
    Jourdan T; Szanda G; Rosenberg AZ; Tam J; Earley BJ; Godlewski G; Cinar R; Liu Z; Liu J; Ju C; Pacher P; Kunos G
    Proc Natl Acad Sci U S A; 2014 Dec; 111(50):E5420-8. PubMed ID: 25422468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caspase-11/4 and gasdermin D-mediated pyroptosis contributes to podocyte injury in mouse diabetic nephropathy.
    Cheng Q; Pan J; Zhou ZL; Yin F; Xie HY; Chen PP; Li JY; Zheng PQ; Zhou L; Zhang W; Liu J; Lu LM
    Acta Pharmacol Sin; 2021 Jun; 42(6):954-963. PubMed ID: 32968210
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protective role of cannabinoid receptor type 2 in a mouse model of diabetic nephropathy.
    Barutta F; Piscitelli F; Pinach S; Bruno G; Gambino R; Rastaldi MP; Salvidio G; Di Marzo V; Cavallo Perin P; Gruden G
    Diabetes; 2011 Sep; 60(9):2386-96. PubMed ID: 21810593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
    Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
    Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mesenchymal stem cells ameliorate podocyte injury and proteinuria in a type 1 diabetic nephropathy rat model.
    Wang S; Li Y; Zhao J; Zhang J; Huang Y
    Biol Blood Marrow Transplant; 2013 Apr; 19(4):538-46. PubMed ID: 23295166
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Swiprosin-1 Promotes Mitochondria-Dependent Apoptosis of Glomerular Podocytes via P38 MAPK Pathway in Early-Stage Diabetic Nephropathy.
    Wang RM; Wang ZB; Wang Y; Liu WY; Li Y; Tong LC; Zhang S; Su DF; Cao YB; Li L; Zhang LC
    Cell Physiol Biochem; 2018; 45(3):899-916. PubMed ID: 29421811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MYDGF attenuates podocyte injury and proteinuria by activating Akt/BAD signal pathway in mice with diabetic kidney disease.
    He M; Li Y; Wang L; Guo B; Mei W; Zhu B; Zhang J; Ding Y; Meng B; Zhang L; Xiang L; Dong J; Liu M; Xiang L; Xiang G
    Diabetologia; 2020 Sep; 63(9):1916-1931. PubMed ID: 32588068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Podocyte-specific Nox4 deletion affords renoprotection in a mouse model of diabetic nephropathy.
    Jha JC; Thallas-Bonke V; Banal C; Gray SP; Chow BS; Ramm G; Quaggin SE; Cooper ME; Schmidt HH; Jandeleit-Dahm KA
    Diabetologia; 2016 Feb; 59(2):379-89. PubMed ID: 26508318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice.
    Barutta F; Grimaldi S; Franco I; Bellini S; Gambino R; Pinach S; Corbelli A; Bruno G; Rastaldi MP; Aveta T; Hirsch E; Di Marzo V; Gruden G
    Kidney Int; 2014 Nov; 86(5):979-90. PubMed ID: 24827776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid receptor 1 blockade ameliorates albuminuria in experimental diabetic nephropathy.
    Barutta F; Corbelli A; Mastrocola R; Gambino R; Di Marzo V; Pinach S; Rastaldi MP; Perin PC; Gruden G
    Diabetes; 2010 Apr; 59(4):1046-54. PubMed ID: 20068137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vitamin D3 ameliorates podocyte injury through the nephrin signalling pathway.
    Trohatou O; Tsilibary EF; Charonis A; Iatrou C; Drossopoulou G
    J Cell Mol Med; 2017 Oct; 21(10):2599-2609. PubMed ID: 28664547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophages directly mediate diabetic renal injury.
    You H; Gao T; Cooper TK; Brian Reeves W; Awad AS
    Am J Physiol Renal Physiol; 2013 Dec; 305(12):F1719-27. PubMed ID: 24173355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated cannabinoid receptor 1 and G protein-coupled receptor 55 expression in proximal tubule cells and whole kidney exposed to diabetic conditions.
    Jenkin KA; McAinch AJ; Zhang Y; Kelly DJ; Hryciw DH
    Clin Exp Pharmacol Physiol; 2015 Mar; 42(3):256-62. PubMed ID: 25545857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intra-renal and urinary mRNA expression of podocyte-associated molecules for the estimation of glomerular podocyte loss.
    Wang G; Lai FM; Lai KB; Chow KM; Kwan BC; Li KT; Szeto CC
    Ren Fail; 2010 Jan; 32(3):372-9. PubMed ID: 20370455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reversal of albuminuria by combined AM6545 and perindopril therapy in experimental diabetic nephropathy.
    Barutta F; Bellini S; Mastrocola R; Gambino R; Piscitelli F; di Marzo V; Corbetta B; Vemuri VK; Makriyannis A; Annaratone L; Bruno G; Gruden G
    Br J Pharmacol; 2018 Dec; 175(23):4371-4385. PubMed ID: 30184259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Podocyte EGFR Inhibits Autophagy Through Upregulation of Rubicon in Type 2 Diabetic Nephropathy.
    Li Y; Pan Y; Cao S; Sasaki K; Wang Y; Niu A; Fan X; Wang S; Zhang MZ; Harris RC
    Diabetes; 2021 Feb; 70(2):562-576. PubMed ID: 33239448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FOXO3a accumulation and activation accelerate oxidative stress-induced podocyte injury.
    Chen X; Liu W; Xiao J; Zhang Y; Chen Y; Luo C; Huang Q; Peng F; Gong W; Li S; He X; Zhuang Y; Wu N; Liu Y; Wang Y; Long H
    FASEB J; 2020 Oct; 34(10):13300-13316. PubMed ID: 32786113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DUSP26 regulates podocyte oxidative stress and fibrosis in a mouse model with diabetic nephropathy through the mediation of ROS.
    Huang F; Sheng XX; Zhang HJ
    Biochem Biophys Res Commun; 2019 Jul; 515(3):410-416. PubMed ID: 31155289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperoside reduces albuminuria in diabetic nephropathy at the early stage through ameliorating renal damage and podocyte injury.
    Zhang J; Fu H; Xu Y; Niu Y; An X
    J Nat Med; 2016 Oct; 70(4):740-8. PubMed ID: 27255369
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.